Home > Boards > US Listed > Biotechs >

Sarepta Therapeutics (SRPT)

SRPT RSS Feed
Add SRPT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/28/2021 2:30:30 PM - Followers: 128 - Board type: Free - Posts Today: 0

http://www.sareptatherapeutics.com/

http://www.antivirals.com/

http://finance.yahoo.com/q/h?s=AVII

http://www.form4oracle.com/company?cik=0000873303&ticker=avii

http://www.secform4.com/insider-trading/873303.htm
 

Sarepta Therapeutics - formerly AVI BioPharma - remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta's unique technology has yielded a diverse pipeline of RNA-based therapeutics that include our lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world's most lethal infectious diseases.

Our exceptional science- and commercialization-focused team is committed to realizing our vision of becoming a leading, independent biotechnology company dedicated to translating our RNA-based science into transformational therapeutics and, most importantly, bringing these novel therapeutics to patients who have no other options.

AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products principally based on NEUGENE antisense technology. It offers various drugs for the treatment of cardiovascular diseases, infectious diseases, cancer, and polycystic kidney diseases, as well as for regulating drug metabolism. The company has collaboration agreement with Chiron Corporation for research, development, and commercialization of antisense therapeutics against hepatitis C virus; Cook Group Incorporated for the development and commercialization of products for vascular diseases; and Ercole Biotech, Inc. to identify and develop drugs that direct the splicing of messenger RNA to treat a range of genetic and acquired diseases. AVI BioPharma was founded in 1980 and is based in Portland, Oregon.

SEC Filings

Form Type Received Period Ending Size Report
PRE 14A May 16, 2016 Jun 27, 2016 2.7 MB  PDF    RTF    HTML    XLS
SC 13G May 6, 2016   14.4 KB  PDF    RTF    HTML    XLS
8-K May 5, 2016 May 5, 2016 72.4 KB  PDF    RTF    HTML    XLS
10-Q May 5, 2016 Mar 31, 2016 5.0 MB  PDF    RTF    HTML    XLS
10-K/A Apr 29, 2016 Dec 31, 2015 2.0 MB  PDF    RTF    HTML    XLS
4 Apr 22, 2016 Apr 20, 2016 5.0 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 7.4 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 5.2 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 4.7 KB  PDF    RTF    HTML    XLS
8-K Mar 8, 2016 Mar 7, 2016 30.8 KB  PDF    RTF    HTML    XLS
















Phone and email address..................Lead investigator in the DMD trial.....London College of Medicine

http://www1.imperial.ac.uk/medicine/people/f.muntoni/


 

DISCLAIMER:
•The Board Monitor and The Board Assistants herewith, Are not licensed brokers and assume NO Responsibility for the Actions,
 Investment decisions, and or Messages Posted on this Forum.
•We do NOT recommend that Anyone Buy or Sell any Securities Posted Herewith.
Any Trade entered into Risks the Possibility of Losing the Funds Invested.
•There are NO Guarantees when Buying or Selling Any Security.

 


 

SRPT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SRPT News: Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on Mar... 02/22/2021 08:30:00 AM
SRPT News: Statement of Ownership (sc 13g) 02/16/2021 11:41:44 AM
SRPT News: Schedule 13g 02/10/2021 12:30:20 PM
SRPT News: Amended Statement of Ownership (sc 13g/a) 02/10/2021 12:05:07 PM
SRPT News: Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition 02/04/2021 04:30:00 PM
PostSubject
#2898   Not trying to hurt anyone's feelings here but quito_yume 01/28/21 02:30:30 PM
#2897   www.stockscores.com/chart.asp?TickerSymbol=SRPT&TimeRange=275&Interval=d& mick 01/12/21 05:12:57 PM
#2896   It's a steady gain. We'll see more recovery WarBuf 01/11/21 03:21:10 PM
#2895   I do like 'dead cat bounce plays" just softballdaddy 01/11/21 10:38:54 AM
#2894   Yup...Been flipping the SH** out of it... Grandmasim 01/11/21 10:20:32 AM
#2893   Are you playing the bounce softballdaddy 01/11/21 10:18:38 AM
#2892   I believe it is oversold (RSI 15%) Grandmasim 01/09/21 02:57:18 PM
#2891   I agree, i got in after the plummet, softballdaddy 01/09/21 09:12:06 AM
#2890   Some mixed results from trial. r clarke 01/08/21 07:04:39 PM
#2889   damn did 2 trades here one from 78 enthalpy 01/08/21 05:29:51 AM
#2888   i agree Sarepta Therapeutics (SRPT) mick 01/07/21 07:45:46 PM
#2887   Wow what happened here? 50% drop, that's insane MD3 01/07/21 06:38:06 PM
#2886   Sarepta Therapeutics (SRPT) mick 11/23/20 09:53:32 AM
#2885   News: $SRPT Sarepta Therapeutics Announces Partnership with Roche whytestocks 12/23/19 06:00:29 PM
#2884   No thanks. I try to avoid stocks that r clarke 12/19/19 01:40:39 PM
#2883   CONGRATS on your success sushifishman 12/14/19 01:46:08 PM
#2882   Vyondys 53 approval is great news, but can r clarke 12/13/19 01:25:58 PM
#2881   News: $SRPT Sarepta Therapeutics Announces $250 Million of whytestocks 12/13/19 10:45:11 AM
#2880   $140 coming T695 12/12/19 07:13:13 PM
#2879   $SRPT bulls and bears https://news.squeezereport.com/short-squeeze/s whytestocks 12/04/19 03:10:30 PM
#2878   News: $SRPT These 3 Value Stocks Are Absurdly whytestocks 11/22/19 11:45:35 PM
#2877   News: $SRPT Sarepta Therapeutics Announces Positive Functional Results whytestocks 10/04/19 09:50:29 AM
#2876   Yes Yoy Yoy. Glider549 08/20/19 05:21:32 PM
#2875   Duuuude.....get lost Yoyippie 08/20/19 05:20:30 PM
#2874   There are far better ones with upcoming catalysts Glider549 08/20/19 05:08:00 PM
#2873   Not invested in Srpt but thanks for asking! Yoyippie 08/20/19 04:57:29 PM
#2872   How is SRPT working out for ya? Glider549 08/20/19 03:56:30 PM
#2871   https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta north40000 08/19/19 06:45:53 PM
#2870   Wtf are you doing on ihub!? Yiu got Yoyippie 08/08/19 12:48:25 PM
#2869   Moved up a bit too much today? r clarke 06/28/19 04:39:50 PM
#2868   130 by end of the week! Gondy 04/30/19 09:57:24 AM
#2867   Was there a 930k sell off . Edgarf 04/22/19 02:53:55 AM
#2866   It is good to see much needed funding MedResCollab 02/04/19 08:31:48 AM
#2865   Surprise this page is not active as others . Edgarf 11/07/18 09:29:21 PM
#2864   Might be a buyer at about 100. eyeofstorm 06/27/18 01:57:44 PM
#2863   Good article on Sarepta Inoviorulez 06/20/18 07:19:03 AM
#2862   Great time to have this stock. Their joanne4trade 06/19/18 12:31:00 PM
#2861   HFS!!! I am glad I kept half of antferrara1 06/19/18 11:06:11 AM
#2860   http://www.stockscores.com/charts/charts/?ticker=SRPT mick 04/07/18 12:39:27 PM
#2859   WONDER COMPANY $SRPT mick 04/07/18 12:39:15 PM
#2858   http://www.barchart.com/detailedquote/stocks/SRPT mick 02/24/18 03:11:15 PM
#2857   Sarepta Therapeutics (SRPT) mick 01/23/18 07:39:44 PM
#2856   You probably did not see AMZN’s data in AuthenticChef 01/10/18 01:53:13 PM
#2854   Can anyone help me to understand how a FishyFingers 01/03/18 02:14:47 AM
#2853   http://www.barchart.com/opinions/stocks/SRPT mick 12/01/17 07:21:20 AM
#2852   https://www.stockscores.com/charts/charts/?ticker=SRPT mick 10/08/17 01:49:55 PM
#2851   BOOM! Premarket action, love it! foxwoodsfan 09/06/17 08:52:36 AM
#2850   https://seekingalpha.com/news/3293771-sareptas-golodirsen-shows-treatment-effect Avispa 09/06/17 07:57:46 AM
#2849   could be buyout thing $srpt mick 08/31/17 03:06:40 PM
#2848   Major resistance level here, will it break through? foxwoodsfan 08/31/17 02:19:00 PM
PostSubject
Consent Preferences